| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.83B | +9.1% |
| R&D Expense | $643.0M | -2.3% |
| SG&A Expense | $2.46B | -5.9% |
| Operating Income | $3.08B | +33.0% |
| Pre-tax Income | $3.27B | +23.0% |
| Income Tax | $257.0M | -62.5% |
| Net Income | $2.98B | +53.3% |
| EPS (Basic) | $3.00 | +55.4% |
| EPS (Diluted) | $2.98 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $7.12B | +0.7% |
| Inventory | $4.95B | -2.7% |
| Current Assets | $17.21B | +5.6% |
| Total Assets | $38.36B | +3.8% |
| Current Liabilities | $12.99B | +0.0% |
| Long-term Debt | $5.97B | +1.7% |
| Stockholders' Equity | $16.89B | +9.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.33B | +8.8% |
| Investing Cash Flow | -$1.02B | -24.4% |
| Financing Cash Flow | -$1.53B | +24.7% |
| +56.0% |